- Pharmacokinetics of enrofloxacin HCl-2Hâ‚‚O (Enro-C) in dogs and pharmacokinetic/pharmacodynamic Monte Carlo simulations against Leptospira spp.
-
Sumano H, Ocampo L, Tapia G, Mendoza CD, Gutierrez
- KMID: 2420928
- J Vet Sci.
- 2018 Sep;19(5):600-607.
- doi: 10.4142/jvs.2018.19.5.600
Pharmacokinetic/pharmacodynamic (PK/PD) ratios of reference enrofloxacin (Enro-R) and enrofloxacin as HCl-2H₂O (Enro-C), as well as Monte Carlo simulations based on composite MIC₅₀ and MIC₉₀ (MIC, minimum inhibitory concentration) vs. Leptospira... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful treatment of recurrent subclinical mastitis in cows caused by enrofloxacin resistant bacteria by means of the sequential intramammary infusion of enrofloxacin HCl-2H 2 O and ceftiofur HCl: a clinical trial
-
Alfonseca-Silva E, Cruz-Villa JC, Gutiérrez L, Sumano H
- KMID: 2522877
- J Vet Sci.
- 2021 Nov;22(6):e78.
- doi: 10.4142/jvs.2021.22.e78
Background: Recurrent subclinical mastitis (RScM) due to resistant bacteria has low clinical and bacteriological cure rates, often requiring the culling of cows. The sequential intramammary administration of enrofloxacin hydrochloride-dihydrate (enro-C)... -
- CITED
-
- Close
- SHARE
-
- Close
- A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs.ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows
-
Ortega E, Alfonseca-Silva E, Posadas E, Tapia G, Sumano H
- KMID: 2509149
- J Vet Sci.
- 2020 Nov;21(6):e87.
- doi: 10.4142/jvs.2020.21.e87
Background: A new, extended long-acting tilmicosin (TLAe) preparation was tested against intramammary ceftiofur (CEF) using a non-inferiority trial model during dry-cow therapy (DCT) in a farm with high bovine population... -
- CITED
-
- Close
- SHARE
-
- Close
